Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 809 results for "Treatment For Multiple Sclerosis"

Copaxone sales hit new record

Copaxone sales hit new record

Teva's multiple sclerosis treatment enjoyed rising second quarter sales despite the launch of Globes, 2 days ago
Olds Albertan

CMSC Press Release: Multiple Sclerosis Coalition Applauds Passage of 21st Century Cures Act

Multiple Sclerosis Coalition Applauds Passage of 21st Century Cures Act Inclusion of data-gathering provision is vital to future MS re Cherry Hill, NJ • July 10, 2015 -The member organizations of the Multiple Sclerosis Coalition (MSC) ...
 Noodls2 days ago Slo-pitch tournament raises money for multiple sclerosis research  Olds Albertan3 days ago Multiple sclerosis relapse management: an interview with Gina Remington  News-Medical.Net5 days ago Multiple Sclerosis: Top 10 Treatment Centers  NewsMax.com1 week ago
Med India

Brain Scan Software For Early Detection Of Multiple Sclerosis, Brian Tumors

New software has been developed by scientists at the Royal Melbourne Hospital to detect tiny changes in the brain caused by Multiple Sclerosis, brain tumors and other disorders. Dr Frank Gaillard, Hospital director of research, said that it is very important ...
 Med India4 days ago Multiple sclerosis breakthrough: Scientists develop technology to assist doctors in detection of brain lesions  ABC Online5 days ago
New Zealand Herald

Cannabis spray considered for public funding

A cannabis spray used to treat epilepsy, pain and multiple sclerosis will be considered for public funding next month. Pharmac, the agency responsible for deciding which medicines get subsidised, plans to discuss the Sativex spray with its primary ...
 New Zealand Herald5 days ago First Australian medical cannabis clinical trial greenlighted days ago Cannabis news 'exciting' - Renton  The Press NZ4 days ago 'Exciting' development in medicinal cannabis debate days ago

Nutra Pharma files orphan drug application for multiple sclerosis drug with FDA

Nutra Pharma Corporation, a biotechnology company, has filed an application with the FDA for orphan drug status of the company's RPI-78M drug candidate for the treatment of multiple sclerosis in children. "In May, we announced that we had engaged ...
 Individual.com1 week ago Nutra Pharma submits orphan drug application to FDA for RPI-78M to treat multiple sclerosis  Pharmaceutical Business Review2 weeks ago

Austrian's plea against deportation unbelievable, HC told

An Austrian citizen's plea against deportation citing ongoing Ayurvedic treatment for multiple sclerosis at Thiruvananthapuram was unbelievable, an inquiry conducted by ministry of home afairs has concluded.
 Times of India2 weeks ago

Natco Pharma gains as US Supreme Court invalidates rival Teva's patent for Copaxone

Copaxone (Glatiramer Acetate) is used in the treatment of relapsing-remitting multiple sclerosis.
 Economic Times1 month ago US Supreme Court invalidates Teva patent for Copaxone  Business Standard1 month ago

Flex Pharma Announces Two Poster Presentations at Upcoming Scientific Meetings

Abstracts accepted at the European Committee for Treatment and Research of Multiple Sclerosis and the Society for Neuroscience BOSTON--(BUSINESS WIRE)--Jul. 28, 2015-- Click to Tweet this News Flex Pharma 1. The 31st Congress of the European ...
 Bloomberg4 days ago Flex Pharma (FLKS) Announces Two Poster Presentations At Upcoming Scientific Meetings 7/28/2015  ClinicSpace3 days ago FLEX PHARMA : Announces Two Poster Presentations at Upcoming Scientific Meetings  4 Traders4 days ago Flex Pharma : Updates on 2 Poster Presentations at Upcoming Scientific Meetings  4 Traders1 day ago
MedCity News

Neuro Vigor repurposing blood pressure drug for multiple sclerosis

Indiana startup Neuro Vigor has founda new use for a long-approved hypertension drug treating neurodegenerative disease like neuropathies, Parkinson's, and multiple sclerosis. The Purdue University spinout is built on 15 years of researchfrom ...
 MedCity News1 week ago

Biogen's Multiple Sclerosis Drugs Show 2Q15 Growth

Biogen's 2Q15 Earnings Beat Wall Street Estimates ( Continued from Prior Part ) Multiple sclerosis Biogen's (BIIB) revenues from multiple sclerosis (or MS) drugs increased by a modest 1.3%, from $2.3 billion in 1Q14 to $2.6 billion in 2Q15.
 Yahoo! Finance2 days ago Why Sandoz Revenues Were Important for Novartis in 2Q15  Yahoo! Finance3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Treatment For Multiple Sclerosis
Get updated on latest news & your favorite topics right in your inbox!
More     Less